1. Serine-threonine kinase TAO3-mediated trafficking of endosomes containing the invadopodia scaffold TKS5α promotes cancer invasion and tumor growth
- Author
-
Manuela Quintavalle, Fu Yue Zeng, Christian A. Hassig, Shinji Iizuka, Shannon K. McWeeney, Robert Ardecky, Sara A. Courtneidge, Ian Pass, Matthew Mark Abelman, Anthony B. Pinkerton, Jose Navarro, Eduard Sergienko, Chen Ting Ma, George Thomas, and Kyle P. Gribbin
- Subjects
0301 basic medicine ,Scaffold protein ,Cytoplasmic Dyneins ,Male ,Cancer Research ,Skin Neoplasms ,Endosome ,Protein subunit ,Datasets as Topic ,Antineoplastic Agents ,Endosomes ,Protein Serine-Threonine Kinases ,Time-Lapse Imaging ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Cell Line, Tumor ,Animals ,Humans ,Neoplasm Invasiveness ,Melanoma ,Serine/threonine-specific protein kinase ,Gene knockdown ,Chemistry ,Kinase ,Gene Expression Profiling ,Phosphoproteomics ,Xenograft Model Antitumor Assays ,Cell biology ,Extracellular Matrix ,High-Throughput Screening Assays ,Adaptor Proteins, Vesicular Transport ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Gene Knockdown Techniques ,Invadopodia ,Podosomes ,Female - Abstract
Invadopodia are actin-based proteolytic membrane protrusions required for invasive behavior and tumor growth. In this study, we used our high-content screening assay to identify kinases whose activity affects invadopodia formation. Among the top hits selected for further analysis was TAO3, an STE20-like kinase of the GCK subfamily. TAO3 was overexpressed in many human cancers and regulated invadopodia formation in melanoma, breast, and bladder cancers. Furthermore, TAO3 catalytic activity facilitated melanoma growth in three-dimensional matrices and in vivo. A novel, potent catalytic inhibitor of TAO3 was developed that inhibited invadopodia formation and function as well as tumor cell extravasation and growth. Treatment with this inhibitor demonstrated that TAO3 activity is required for endosomal trafficking of TKS5α, an obligate invadopodia scaffold protein. A phosphoproteomics screen for TAO3 substrates revealed the dynein subunit protein LIC2 as a relevant substrate. Knockdown of LIC2 or expression of a phosphomimetic form promoted invadopodia formation. Thus, TAO3 is a new therapeutic target with a distinct mechanism of action. Significance: An unbiased screening approach identifies TAO3 as a regulator of invadopodia formation and function, supporting clinical development of this class of target.
- Published
- 2021